Quick Answer
GOLDENWELL BIOTECH, INC. reported Total Revenue of $139.00 for fiscal year 2024.
GOLDENWELL BIOTECH, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $139.00 | -92.4% |
| 2023 | $1.8K | -96.2% |
| 2022 | $47.8K | +199.4% |
| 2021 | $16.0K | — |
| 2020 | $0.00 | — |
| 2019 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| March 31, 2025 | $0.00 | — | — |
| September 30, 2024 | $0.00 | -100.0% | -100.0% |
| June 30, 2024 | $139.00 | -49.6% | — |
| March 31, 2024 | $0.00 | -100.0% | -100.0% |
| September 30, 2023 | $382.00 | -99.1% | +38.4% |
| June 30, 2023 | $276.00 | -92.6% | -80.6% |
| March 31, 2023 | $1.4K | +258.2% | -96.7% |
- GOLDENWELL BIOTECH, INC. showed a decrease of -92.4% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from GOLDENWELL BIOTECH, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: